Where it is registered
Each register with its number of medicines and a few of them.
United States
FDA · 3 medicines
New Zealand
PHARMAC · 2 medicines
All medicines with Measles, mumps
Every register, a page at a time. Strengths and packs are on each medicine’s page.
23 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| M-M-R IiCombination | United States | 0.5ML | For Injection | Marketed | Merck Sharp & Dohme LLC |
| M-M-R IiCombination | United States | 0.5ML | For Injection | Marketed | Merck Sharp & Dohme LLC |
| PriorixCombination | United States | 3.4, 4.2 and 3.3LOG10 | For Injection | Marketed | GlaxoSmithKline Biologicals |
| PriorixCombination | New Zealand | Inj, measles virus 1,000 CCID50, mumps virus 5,012 CCID50, Rubella virus 1,000 CCID50; prefilled syringe/ampoule of diluent 0.5 ml | Funded | ||
| PriorixCombination | New Zealand | Injection, measles virus 1,000 CCID50, mumps virus 5,012 CCID50, Rubella virus 1,000 CCID50; prefilled syringe/ampoule of diluent 0.5 ml | Funded | ||
| ProquadCombination | United States | 0.5ML | For Injection | Marketed | Merck Sharp & Dohme LLC |
| ProquadCombination | United States | 0.5ML | For Injection | Marketed | Merck Sharp & Dohme LLC |
| M-M-RVaxPro | European Union | Authorised | Merck Sharp & Dohme B.V. | ||
| ProQuad | European Union | Authorised | Merck Sharp & Dohme B.V. | ||
| M-M-R IICombination | Canada | 1000 CCID50 / 0.5 ML + 5000 CCID50 / 0.5 ML + 1000 CCID50 / 0.5 ML | Powder For Solution | Marketed | Merck Canada INC |
| PriorixCombination | Canada | 1000 CCID50 / 0.5 ML + 5011.8723 CCID50 / 0.5 ML + 1000 CCID50 / 0.5 ML | Kit, Powder For Solution | Marketed | Glaxosmithkline INC |
| Priorix-TetraCombination | Canada | 1000 CCID50 / 0.5 ML + 25118.9 CCID50 / 0.5 ML + 1000 CCID50 / 0.5 ML + 1995.2623 PFU / 0.5 ML | Powder For Solution | Marketed | Glaxosmithkline INC |
| ProquadCombination | Canada | 3.00 Log10 TCID50 / 0.5 ML + 4.30 Log10 TCID50 / 0.5 ML + 3.00 Log10 TCID50 / 0.5 ML + 3.99 Log10 PFU / 0.5 ML | Powder For Solution | Marketed | Merck Canada INC |
| M-M-R II VaccineCombination | Singapore | min 1000 CCID50/0.5 ml + min 12500 CCID50/0.5ml + min 1000 CCID50/0.5 ml | injection, powder, for solution | Authorised | MSD Pharma (Singapore) Pte. LTD. |
| Priorix-TetraCombination | Singapore | ≥ 10³ CCID50/dose + ≥ 10⁴·⁴ CCID50/dose + ≥ 10³ CCID50/dose + ≥ 10³·³ PFU/dose | injection, powder, lyophilized, for solution | Authorised | Glaxosmithkline Pte LTD |
| Priorix VaccineCombination | Singapore | min 1000 TCID50 + min 5000 TCID50 + min 1000 TCID50 | injection, powder, for solution | Authorised | Glaxosmithkline Pte LTD |
| ProQuad Refrigerator Stable FormulationCombination | Singapore | 3.00 log TCID 50/ dose + 4.30 log TCID 50/ dose + 3.00 log TCID 50/ dose + 3.99 log PFU/ dose | injection, powder, lyophilized, for solution | Authorised | MSD Pharma (Singapore) Pte. LTD. |
| M.M.R II 0.5ML Vaccine+ 0.7ML DiluentCombination | Saudi Arabia | Authorised | Merck Sharp and Dohme LLC | ||
| M.M.R II 0.5ML Vaccine+ 0.7ML DiluentCombination | Saudi Arabia | Authorised | Merck Sharp and Dohme LLC | ||
| Priorix 0.5ML VialCombination | Saudi Arabia | Authorised | Glaxosmithkline (GSK) | ||
| Priorix 0.5ML VialCombination | Saudi Arabia | Authorised | Glaxosmithkline (GSK) | ||
| Priorix-Tetra VaccineCombination | Saudi Arabia | Authorised | Glaxosmithkline (GSK) | ||
| Priorix-Tetra VaccineCombination | Saudi Arabia | Authorised | Glaxosmithkline (GSK) |
Brand names
The same brand on several registers.
Companies
The companies holding its medicines, the most first.
Sources
Compiled by Prognia from the public medicine registers of FDA and PHARMAC. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.
At a glance
- Registers
- 2
- Medicines
- 5
- Companies
- 2